Cancer cachexia demonstrates the energetic impact of gluconeogenesis in human metabolism von Bongaerts, G.P.A., van Halteren, H.K., Verhagen, C.A.M., Wagener, D.J.Th

Volltext

Phase II trial of CPT-11 in patients with advanced pancreatic cancer, an EORTC early clinical trials group study von Wagener, D. J. Th, Verdonk, H. E. R., Dirix, L. Y., Catimel, G., Siegenthaler, P., Buitenhuis, M., Mathieu-Boué, A., Verweij, J.

Volltext

Weekly high-dose 5-fluorouracil and folinic acid in metastatic pancreatic carcinoma: a phase II study of the EORTC GastroIntestinal Tract Cancer Cooperative Group von Van Rijswijk, R.E.N., Jeziorski, K., Wagener, D.J.TH, Van Laethem, J.-L., Reuse, S., Baron, B., Wils, J.

Volltext

Effect of carbogen breathing on the pharmacodynamics of 5-fluorouracil in a murine colon carcinoma von Kamm, Y.J.L., Heerschap, A., Wagener, D.J.Th

Volltext

Activity of cisplatin in adenocarcinoma of the pancreas von Wils, J.A., Kok, T., Wagener, D.J.Th, Selleslags, J., Duez, N.

Volltext

Oral ZD9331, a non-polyglutamated thymidylate synthase (TS) inhibitor: a phase I and pharmacologic study von de Jonge, M.J.A., Punt, C.J.A., Planting, A.S.T., Wagener, D.J.Th, Jackman, A., Smith, R., Smith, M., Verweij, J.

Volltext

Quantitative ultrasonic analysis of liver metastases von HUISMAN, H. J, THIJSSEN, J. M, WAGENER, D. J. T, ROSENBUSCH, G. J. E

Volltext

The ESMO programme of certification and training for medical oncology von Wagener, D. J. Th, Vermorken, J. B., Hansen, H. H., Hossfeld, D. K.

Volltext

Results of a phase II trial of epirubicin and cisplatin (EP) before and after irradiation and 5-fluorouracil in locally advanced pancreatic cancer: An EORTC GITCCG study von Wagener, D.J.Th, Hoogenraad, W.J., Rougier, Ph, Lusinchi, A., Taal, B.G., Veenhof, C.H.N., de Graeff, A., Conroy, T., Curran, D., Sahmoud, T., Wils, J.

Volltext

Pancreatic Cancer: Current status and future directions in the perioperative treatment of pancreatic cancer von Wagener, D. J. Th, Punt, C. J. A., Wilke, H.

Volltext

Pancreatic Cancer: Multimodality treatment of locally advanced pancreatic cancer von Wagener, D. J. Th, de Mulder, P. H. M., Wils, J. A.

Volltext

Combined modality adjuvant treatment of high-risk rectal cancer: A treatment of choice or a choice of treatment? von Wils, J., Wagener, D. J. Th

Volltext

Phase II trial with ifosfamide in pancreatic cancer von Wils, J.A., Kok, T., Wagener, D.J.Th, Francois, E., Selleslags, J., Duez, N.

Volltext

Phase II study of sequential high-dose methotrexate (MTX) and 5-fluorouracil (F) alternated with epirubicin (E) and cisplatin (P) [FEMTX-P] in advanced gastric cancer von Roelofs, E. J. M., Wagener, D. J. Th, Conroy, Th, Wils, J., Burghouts, J. Th, Fickers, M., de Graeff, A., Lalisang, F., Paillot, B.

Volltext

HYPOTHYROIDISM AND GOITRE DURING INTERLEUKIN-2 THERAPY WITHOUT LAK CELLS von Liessum, P.A.Van, De Mulder, P.H.M., Mattijssen, E.J.M., Corstens, F.H.M., Wagener, D.J.Th

Volltext

In vivo potentiation of cisplatin antitumor activity by ethyldeshydroxy-sparsomycin von Hofs, H.P., Wagener, D.J.Th, Ottenheijm, H.C.J.

Volltext

Vinorelbine (Navelbine ®) is an active drug in metastatic epidermoid esophageal carcinoma (MEEC) von Conroy, T., Etienne, P.-L., Adenis, A., François, E., Wagener, D.J.Th, Paillot, B., Wils, J., Seitz, J.-F., Delgado, F.M., Merle, S., Van Pottelsberghe, C., Van Glabbeke, M., Bleiberg, H.

Volltext

"INCUBATION PERIOD" IN HODGKIN'S DISEASE von Wagener, D.J.Th, Haanen, C.

Volltext

Phase II study of nimustine in metastatic soft tissue sarcoma von Wagener, D.J.Th, Somers, R., Santoro, A., Verweij, J., Woll, P.J., Blackledge, G., Schütte, H.J., Lentz, M.A., van Glabbeke, M.

Volltext

BIMODALITY IN HODGKIN'S DISEASE von Wagener, D.J.Th

Volltext